leisure time -WSS

leisure time

author：Wikipedia 2025-09-29 01:45:24 - browse：29

SAN DIEGO — After starting off the year with lower revenue projections than market analysts had hoped for, San Diego-based genomics giant Illumina lowered expectations again on Wednesday, forecasting annual growth of 1% compared to the previous year.

The market’s response was swift. Minutes after the company issued its press release, shares in Illumina dipped from $184.49 to below $172 during after-hours trading.

In its release, Illumina noted that it expects revenue from the company’s core business to be essentially the same this year compared to last, and that it expects revenue from Grail, the cancer diagnostics company that Illumina acquired for $8 billion in the fall of 2021, to remain in the range of $90 and $100 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： As AI in medicine takes off, can 'human in the loop' prevent harm?

hotspot

focus

WSS

Diabetes management: Digital health tools fall short, study says

Yancopoulos of Regeneron works to expand Dupixent success

This gene therapy has record $4.25 million price. It's saved children.

Amid AI frenzy, a top HHS official's quest to create safeguards

How to save health care price transparency rules

John Green on his newest strategy for fighting tuberculosis

hotspot

leisure time

focus

Apple is now the first public company to be valued at $3 trillion

What Kate Middleton's cancer revelation might teach the world

Cancer drug shortages should be causing more outrage

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Alkermes shareholders re

How to save health care price transparency rules

In age of alternative facts, a scholarly course on calling out crap

Pfizer, Moderna say biotech, pharma drug development is a sprint

hotspot

Pregnancy ages women, but effects reverse after delivery

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Texas board proposes rules on abortion law emergency exemption

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

hotspot

focus

Wikipedia

hotspot